When combining HER2 scores with Ki67 or tumor sizes, the results showed a significant difference (P < 0.05) in the groups with Ki67 > 30% and tumor sizes ≤ 2 cm for the Nby-Aby diagnosis compared to the conventional method. The gene discussed is ERBB2; the disease is neoplasm.